Commercial positioning case studies
Increasing the reach and return on investment in your clinical data with innovative solutions
Learn more about our commercialisation & outcomes expertise in this case study library.
We help pharma, device, and biotechnology companies at every stage of development—from endpoint selection and PRO development, through clinical trials, to post-approval and scientific publication.
Rapid manuscript development and delivery
Through close collaboration with a client, the ICON team provided the support necessary to advance a critical COVID-19 manuscript from outline through submission to acceptance in only 20 days.
PKU-specific HRQol Questionnaire Development & Validation
ICON developed the first PKU-specific Quality of Life questionnaire available and validated in four age groups and seven languages.
Retrospective Chart Review Study in Patients with Osteoporosis
This study was conducted to describe clinical characteristics and current treatment practices for patients with osteoporosis at high risk factor in Japan.
Seamless transition from PMA to post-market study
The manufacturer consulted ICON, which had been providing full-service clinical coverage for the PMA study, to economically and seamlessly transition the PMA study participants to the mandated PAS.
Rapid post-market study start-up
The MDDR team developed a study protocol and start-up plan that enabled execution several months faster than a typical study. The team also transitioned from a PMA study to a PAS study.